[144] Entrada Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Travel + Leisure Co. (TNL) has filed a Form 144 indicating a potential sale of 15,396 common shares through Merrill Lynch on or after 1 July 2025. At an aggregate market value of roughly $825,225, the transaction equals about 0.02 % of the company’s 66.4 million shares outstanding. The shares stem from restricted-stock-unit vesting on 10 & 14 March 2025 and no other insider sales were reported during the past three months. The filer certifies there is no undisclosed adverse information about the issuer.

Form 144 is a notice—execution is not guaranteed—and it contains no operational or earnings data. Given the small fraction of equity involved, the filing is viewed as routine and unlikely to exert material pressure on TNL’s share price.

Insights

Securities Analyst

TL;DR: Minor Form 144 sale (0.02 % float) appears routine; limited market impact expected.

This planned disposal of 15,396 shares is well below materiality thresholds. It originates from recent RSU vesting rather than discretionary selling, suggesting standard liquidity management rather than a negative signal. The notice lacks performance data, so it does not alter fundamental valuation models. I classify the filing as informational and neutral for investors.

Portfolio Manager

TL;DR: Insider sale is negligible; no portfolio action warranted.

The proposed sale equates to roughly one trading day’s average volume for many mid-caps and is just 0.02 % of shares outstanding. Such a small divestiture does not change liquidity, ownership concentration, or governance risk. I view the event as not impactful to position sizing or risk metrics.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	TD Securities (USA) LLC 1 Vanderbilt Ave New York NY 10017	18578	132323.66	37953417	07/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/28/2017	Venture Investment	Entrada Therapeutics, Inc.			18578	09/28/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
5AM Ventures V, L.P. 4 Embarcadero Center, Suite 3110 San Francisco CA 94111	Common	06/27/2025	55735	385128.85
5AM Ventures V, L.P. 4 Embarcadero Center, Suite 3110 San Francisco CA 94111	Common	06/30/2025	18578	126566.34

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is Travel + Leisure Co. (TNL) filing on Form 144?

It is a notice of intent by an insider to sell 15,396 common shares under Rule 144 of the Securities Act.

How many TNL shares are planned for sale and what is their value?

The filing covers 15,396 shares with an aggregate market value of about $825,225.

What percentage of TNL’s shares outstanding does this represent?

Approximately 0.02 % of the 66.4 million shares outstanding.

When is the planned sale date for the TNL shares?

The filer lists an approximate sale date of 1 July 2025.

Where will the TNL shares be sold and through which broker?

The shares are slated for the NYSE via broker Merrill Lynch, Iselin NJ.

What is the source of the shares being sold?

They were acquired through restricted-stock-unit vesting on 10 & 14 March 2025.